REG - Litigation Cap. Mgmt - Covenant Waiver Extension

Litigation Capital ManagementAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251230:nRSd0465Na&default-theme=true

RNS Number : 0465N  Litigation Capital Management Ltd  30 December 2025

30 December 2025

Litigation Capital Management Limited

("LCM" or the "Company")

Covenant Waiver Extension

 

Litigation Capital Management Limited ("LCM"), an alternative asset manager
specialising in dispute financing solutions internationally, announces that
the debt covenant waiver from its lender, Northleaf Capital Partners (Canada)
Ltd ("Northleaf"), that was due to expire on 30 December 2025 has been
extended to 31 January 2026.  During the extended waiver period the interest
on the loan remains increased by 2.00% per annum consistent with the initial
waiver.  There is no additional one-time waiver fee in relation to this
extension.

The Strategic Review that was first announced on 15 September 2025 has
continued to progress and this waiver extension is reflective of Northleaf's
ongoing support.  LCM management will provide an update on the progress of
the Strategic Review in the new year.

 

 

 

Enquiries

 Litigation Capital Management
 Patrick Moloney, Chief Executive Officer

 David Collins, Chief Financial Officer

 Cavendish (Nomad and Broker)                               Tel: 020 7220 0500
 Jonny Franklin-Adams and Isaac Hooper (Corporate Finance)

 Tim Redfern (Corporate Broking)

 

www.lcmfinance.com (http://www.lcmfinance.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBKLLLELLEFBF



            Copyright 2019 Regulatory News Service, all rights reserved